PRESS RELEASEUrteste plans to start clinical trials for its pancreatic cancer test in Europe in Q3 2025 Gdańsk, ...

The following is a summary of "Nonlinear association between hematocrit levels and short-term all-cause mortality in ICU ...

In the latest installment of Healio’s video series with ASGE, Fiyinfoluwa O. Abraham, MD, discusses ethnic and racial disparities observed in the incidence of pancreatic cancer, demonstrating the need ...

With strong progression-free survival benefits demonstrated in the CABINET trial and updates to National Comprehensive Cancer Network guidelines, this approval reinforces cabozantinib’s role in ...

The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.

Actuate Therapeutics' elraglusib shows promise for pancreatic cancer, but financial instability and risks make it a high-risk ...

Cancer advocates, researchers, clinicians and patients are speaking out in a new STAT News article published this week about the [...] READ MORE ...

Black Americans face higher rates and lower survival. Research explores biological, social factors, and disparities.

Irene Wells didn't ask just how bad her pancreatic cancer was — she just wanted aggressive treatment so she could do "a ...

A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.

Understanding pancreatic cancer symptoms can help individuals seek medical attention sooner, potentially improving outcomes.